Doses (mSv) to 9-Month-Pregnant Models from 18.5-MBq 2-Day Protocol
| Organ | Reference model | MSKCC model | MSKCC childbearing model |
|---|---|---|---|
| Adrenals | 3.59E−02 | 3.25E−02 | 3.38E−02 |
| Brain | 2.70E−03 | 2.44E−03 | 2.53E−03 |
| Injected breast | 1.49E+01 | 5.49E+00 | 7.47E+00 |
| Gallbladder wall | 2.92E−02 | 2.65E−02 | 2.75E−02 |
| LLI wall | 5.89E−03 | 5.33E−03 | 5.53E−03 |
| Small intestine | 3.50E−02 | 3.17E−02 | 3.28E−02 |
| Stomach wall | 5.89E−02 | 5.33E−02 | 5.53E−02 |
| ULI wall | 3.37E−02 | 3.04E−02 | 3.16E−02 |
| Heart wall | 2.14E−01 | 1.93E−01 | 2.01E−01 |
| Kidneys | 1.53E−02 | 1.38E−02 | 1.43E−02 |
| Liver | 6.20E−02 | 5.61E−02 | 5.82E−02 |
| Lungs | 1.51E−01 | 1.37E−01 | 1.42E−01 |
| Muscle | 3.32E−02 | 3.00E−02 | 3.11E−02 |
| Ovaries | 3.63E−03 | 3.27E−03 | 3.39E−03 |
| Pancreas | 4.45E−02 | 4.03E−02 | 4.18E−02 |
| Red marrow | 3.51E−02 | 3.17E−02 | 3.28E−02 |
| Osteogenic cells | 5.74E−02 | 5.18E−02 | 5.38E−02 |
| Skin | 5.52E−02 | 4.99E−02 | 5.18E−02 |
| Spleen | 3.09E−02 | 2.80E−02 | 2.89E−02 |
| Thymus | 1.63E−01 | 1.48E−01 | 1.53E−01 |
| Thyroid | 2.35E−02 | 2.13E−02 | 2.21E−02 |
| Bladder wall | 2.31E−03 | 2.08E−03 | 2.16E−03 |
| Uterus | 1.60E−02 | 1.44E−02 | 1.50E−02 |
| Fetus | 1.37E−02 | 1.24E−02 | 1.28E−02 |
| Placenta | 2.93E−02 | 2.66E−02 | 2.75E−02 |
| Total body | 7.47E−02 | 6.69E−02 | 6.97E−02 |
| Effective dose | 4.60E−01 | 1.86E−01 | 2.45E−01 |